Ustekinumab versus adalimumab for induction and maintenance therapy in biologic-naive patients with moderately to severely active Crohn's disease: a multicentre, randomised, double-blind, parallel-group, phase 3b trial
Titel:
Ustekinumab versus adalimumab for induction and maintenance therapy in biologic-naive patients with moderately to severely active Crohn's disease: a multicentre, randomised, double-blind, parallel-group, phase 3b trial
Auteur:
Sands, Bruce E Irving, Peter M Hoops, Timothy Izanec, James L Gao, Long-Long Gasink, Christopher Greenspan, Andrew Allez, Matthieu Danese, Silvio Hanauer, Stephen B Jairath, Vipul Kuehbacher, Tanja Lewis, James D Loftus Jr, Edward V Mihaly, Emese Panaccione, Remo Scherl, Ellen Shchukina, Oksana B Sandborn, William J